Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?

[1]  J. Kountouras,et al.  Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. , 2013, Metabolism: clinical and experimental.

[2]  K. Madan,et al.  Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease , 2012, The Indian journal of medical research.

[3]  G. Nardone,et al.  Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[5]  S. Das,et al.  Non-alcoholic fatty liver disease in subjects with type 2 diabetes mellitus and non-diabetics with special reference to insulin resistance and hepatic histopathological changes , 2010 .

[6]  Bijay Misra,et al.  Insulin resistance and beta cell function as prognostic indicator in multi-organ dysfunction syndrome. , 2009, Metabolic syndrome and related disorders.

[7]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[8]  Anoop Misra,et al.  Obesity and the metabolic syndrome in developing countries. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  Richard M. Gore.  Diffuse Liver Disease , 2008 .

[10]  K. Pietiläinen,et al.  Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  D. Amarapurkar,et al.  Prevalence of non-alcoholic fatty liver disease: population based study. , 2007, Annals of hepatology.

[12]  S. Bhoi,et al.  Autoimmunity, insulin resistance and Beta cell function in subjects with low body weight type 2 diabetes mellitus. , 2007, Metabolic syndrome and related disorders.

[13]  Rajeev Gupta,et al.  Review: Type 2 diabetes in India: regional disparities: , 2007 .

[14]  K. Madan,et al.  Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. , 2006, World journal of gastroenterology.

[15]  G. Bedogni,et al.  Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.

[16]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[17]  E. Ferrannini,et al.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms , 2005, Diabetologia.

[18]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[19]  S. Caldwell,et al.  The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. , 2004, Journal of hepatology.

[20]  J. George,et al.  Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? , 2004, Journal of gastroenterology and hepatology.

[21]  Manorama Swain,et al.  Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. , 2004, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[22]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[23]  S. Grundy,et al.  Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes , 1985, Diabetologia.

[24]  R. Pandey,et al.  Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. , 2003, Atherosclerosis.

[25]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[26]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[27]  J. Everhart,et al.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.

[28]  J. Schwarz,et al.  Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. , 2003, The American journal of clinical nutrition.

[29]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[30]  Rajeev Gupta,et al.  Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. , 2002, Indian heart journal.

[31]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[32]  J. Grove,et al.  Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis , 1997, Hepatology.

[33]  R. O’Brien,et al.  Regulation of gene expression by insulin. , 1991, Physiological reviews.